Alivus Life Q2 FY26 – Consistent Growth with Strong Profit Momentum

Alivus Life continued its steady performance in Q2 FY26, delivering healthy double-digit growth across revenue and profitability—supported by stable demand and improved margins. • Sales: ↑ 16% YoY to ₹588 crore (vs ₹507 crore in Sep 2024) • EBIDT: ↑ 33% YoY to ₹179 crore (vs ₹134 crore) • Net Profit: ↑ 36% YoY to ₹130 crore (vs ₹95.3 crore) • EPS: ↑ 36% YoY to ₹10.60 (vs ₹7.78) At a price of ₹890, market cap ₹10,925 crore, and PE 20.6, the company maintains a strong earnings trajectory, backed by operational efficiency and sustained bottom-line improvement.